Will this targeted approach be beneficial to other cancer types? Is there any data or theory about this class of drugs as a more general therapy?
Individualized immune cancer therapy has been touted as the next big thing for half a century. It's nothing new, and with few exceptions, such as skin cancer, has failed to yield much. scientists, for decades, have tired to harness the immune system to attackcancer and it almost never works.
Having a plethora of drugs and treatments is vital because cancer is not "one thing". Each type of cancer will respond better to some treatments than others.